IE38655L - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- IE38655L IE38655L IE732267A IE226773A IE38655L IE 38655 L IE38655 L IE 38655L IE 732267 A IE732267 A IE 732267A IE 226773 A IE226773 A IE 226773A IE 38655 L IE38655 L IE 38655L
- Authority
- IE
- Ireland
- Prior art keywords
- hydroxy
- dihydroxyphenyl
- butylaminoethane
- tert
- isopropylaminoethane
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
1453034 Skeletal muscle relaxing preparations BOEHRINGER INGELHEIM GmbH 14 Dec 1973 [15 Dec 1972] 58088/72 Heading A5B . A pharmaceutical composition for use in the treatment of spastically disabled human being comprises a sympathomimetic amine or a physiologically acceptable salt thereof together with an effective amount of sustained or delayed release agent, said amine being: 1-(3, 5-dihydroxyphenyl)-1 -hydroxy-2-isopropylaminoethane; 1-(4-amino-3, 5-dichlorophenyl) - 1 -hydroxy-2-tert-butylaminoethane; 1-(3-hydroxymethyl -4- hydroxyphenyl) -1- hydroxy -2- tert butylaminoethane; 1-(3, 5 - dihydroxyphenyl) -1- hydroxy -2- (1-(4-hydroxybenzyl) ethyl)-aminoethane; 1-(3, 5-dihydroxyphenyl)- 1 -hydroxy-2-tert butylaminoethane; N, N'-bis- [1-(3, 4-dihydroxyphenyl)-1-hydroxyethyl (2)]- hexamethylenediamine; 1-(3, 4-dihydroxyphenyl)-1 -hydroxy-2-isopropylaminoethane; 2-[(3, 4-dihydroxyphenyl) hydroxymethyl] piperidinium hydrobromide; 8-hydroxy-5-( 1 -hydroxy-2- isopropylaminoethyl) quinoline; 1-diphenylmethyl-4-hydroxyethoxyethyl-piperazine; 1 -phenethylpiperidine-4-spiro-5'-[1', 3']-oxazolidin-2'- one; and 1-(2-phenyl-2-methoxyethyl)-4-(3-hydroxy-3-phenylpropyl) piperazine. The composition may be in a form suitable for oral or parenteral administration.
[GB1453034A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5808872A GB1453034A (en) | 1972-12-15 | 1972-12-15 | Pharmaceutical composition for treating spasticity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE38655L true IE38655L (en) | 1974-06-15 |
| IE38655B1 IE38655B1 (en) | 1978-05-10 |
Family
ID=10480743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2267/73A IE38655B1 (en) | 1972-12-15 | 1973-12-14 | Pharmaceutical compositions for treating spasticity |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE808662A (en) |
| DE (1) | DE2362123A1 (en) |
| GB (1) | GB1453034A (en) |
| IE (1) | IE38655B1 (en) |
| IL (1) | IL43820A (en) |
| ZA (1) | ZA739480B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1574894A (en) * | 1977-06-02 | 1980-09-10 | Nippon Kayaku Kk | Derivative of a-methyl-aminopropiophenone and use thereof |
| DE2929456A1 (en) * | 1979-07-20 | 1981-02-05 | Lentia Gmbh | COMPOSITION WITH EXTENDED BRONCHOLYTIC AND TOCOLYTIC EFFECTIVENESS, A METHOD FOR THE PRODUCTION THEREOF AND BRONCHOLYTIC AND TOKOLYTICALLY ACTIVE AGENT |
| CH656308A5 (en) * | 1982-05-27 | 1986-06-30 | Glaxo Group Ltd | PHARMACEUTICAL COMPOSITIONS CONTAINING SALBUTAMOL. |
| US5468501A (en) * | 1982-09-01 | 1995-11-21 | Hercon Laboratories Corporation | Article useful for administration of pharmacologically-active substances transdermally, orally or by means of implant |
| US5310559A (en) * | 1982-09-01 | 1994-05-10 | Hercon Laboratories Corporation | Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer |
| US4525359A (en) * | 1982-12-10 | 1985-06-25 | Greenway Frank L Iii | Treatment for selective weight control |
| JPS6061523A (en) * | 1983-09-16 | 1985-04-09 | Shionogi & Co Ltd | Oral dobutamine pharmaceutical |
| US4751071A (en) * | 1983-12-01 | 1988-06-14 | Alza Corporation | Composition comprising salbutamol |
| US4777049A (en) * | 1983-12-01 | 1988-10-11 | Alza Corporation | Constant release system with pulsed release |
| US4851229A (en) * | 1983-12-01 | 1989-07-25 | Alza Corporation | Composition comprising a therapeutic agent and a modulating agent |
| EP0251425B1 (en) * | 1986-04-03 | 1993-06-16 | Hercon Laboratories Corporation | Article for administration of pharmacologically-active substances |
-
1972
- 1972-12-15 GB GB5808872A patent/GB1453034A/en not_active Expired
-
1973
- 1973-12-14 ZA ZA00739480*DA patent/ZA739480B/en unknown
- 1973-12-14 IE IE2267/73A patent/IE38655B1/en unknown
- 1973-12-14 BE BE138890A patent/BE808662A/en unknown
- 1973-12-14 DE DE2362123A patent/DE2362123A1/en active Pending
- 1973-12-14 IL IL43820A patent/IL43820A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE38655B1 (en) | 1978-05-10 |
| AU6364773A (en) | 1975-06-19 |
| ZA739480B (en) | 1975-08-27 |
| BE808662A (en) | 1974-06-14 |
| GB1453034A (en) | 1976-10-20 |
| IL43820A (en) | 1977-08-31 |
| IL43820A0 (en) | 1974-03-14 |
| DE2362123A1 (en) | 1974-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU93057724A (en) | PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PREPARATION AND METHOD OF TREATMENT | |
| GB2254784B (en) | Film-coated solid dosage form of anti-migraine drug | |
| EP0221041A3 (en) | Benzimidazole derivatives, process for their preparation and their pharmaceutical use | |
| NO944565L (en) | Controlled release preparation containing a morphine salt | |
| BG60102B2 (en) | Method for preparing of 5-fluoro-2[[(4-cyclopropylmethoxy-2-pyridyl)methyl]thionyl]-1h-ben zimidazole | |
| CZ176495A3 (en) | The use of riluzol for preparing a medicament suitable for treating parkinson's disease and parkinson's syndromes | |
| IE38655L (en) | Pharmaceutical compositions | |
| EP0375628A3 (en) | Use of acetyl l-carnitine in the therapeutic treatment of cataract, and pharmaceutical compositions useful in such treatment | |
| IE64850B1 (en) | Therapeutically active substituted benzimidazole and process for its preparation | |
| MY124465A (en) | Reduction of infarct volume using citicoline | |
| KR960003729A (en) | Drugs with antihyperglycemic action | |
| CA2005980A1 (en) | Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation | |
| GB1487334A (en) | Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof | |
| TR200103144T2 (en) | New compounds | |
| GB2209281B (en) | Pharmaceutical compositions comprising an alpha-2 adrenoceptor antagonist | |
| BR0011880A (en) | Method for the treatment of co-morbid conditions associated with obesity, compound, product, use of a compound, and pharmaceutical composition | |
| SE8900751D0 (en) | PHARMACEUTICAL COMPOSITION | |
| DE59205998D1 (en) | Medicament with antineoplastic activity containing octadecyl- [2- (N-methylpiperidino) ethyl] phosphate as active ingredient and process for its preparation | |
| KR930702985A (en) | Treatment of Esophageal Cancer | |
| DK0613375T3 (en) | Pharmaceutical lysine-containing polypeptide preparations and their use | |
| IE37288B1 (en) | Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children | |
| KR980002033A (en) | Triazole derivatives or salts thereof | |
| HK8994A (en) | Medicament for treatment of pregnancy-induced hypertension | |
| KR890701111A (en) | Treatment of dyslipidemia in humans | |
| GB1375806A (en) |